Great Lakes Clinical Trials Initiates a Research Study for Individuals with Hidradenitis Suppurativa (HS)

Great Lakes Clinical Trials is currently enrolling participants for a research study of an investigational medication for the treatment of moderate to severe hidradenitis suppurativa.

What is HS?

Hidradenitis suppurativa (HS) is a long-term skin condition that features small, painful lumps under the skin. They typically develop where the skin rubs together, such as the armpits, the groin, between the buttocks and under the breasts. The lumps may break open and smell or cause tunnels under the skin.

What is this trial studying?

An investigational drug is being studied for patients who have moderate to severe hidradenitis suppurativa. The purpose of this study is to evaluate if the investigational drug works and determine its safety.

To qualify participants must:

  • Be over the age of 18

  • Have been diagnosed with hidradenitis suppurativa for at least one year

  • Have lesions in two distinct areas

  • Had had an inadequate response to an oral antibiotic for treatment of HS

Other entry criteria may apply and will be reviewed with you prior to participation.

What are my costs to participate in this trial?

You will receive all study-related care and study-related drug at no cost. For your participation, you will receive a stipend of $75 for each clinic visit you complete, up to $1,125 for completing the study.

How long with the trial last?

This trial will involve up to 15 visits to our clinic over approximately 1 year.

If you are interested in joining this trial, please complete our on-line survey by clicking here. One of our staff will then follow-up with you within 24 hrs. Otherwise, you can call our center directly at (773) 275-3500 to speak with one of our staff today.